Immunogenetics: Open Access
Open Access
+44 1223 790975
+44 1223 790975
Department of Abdominal Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China
Research
Cost-Effectiveness Analysis of Ultra Hypo-Fractionated Radiotherapy and Conventionally Fractionated Radiotherapy for Intermediate to High Risk
Localized Prostate Cancer
Author(s): Jiaoxue He, Qingfeng Wang, Qiancheng Hu and Changlin Li*
Background: Radiotherapy is an effective curative treatment option for intermediate-to-high-risk localized prostate
cancer. Given that no significant difference was observed in survival and toxicities, we evaluated the cost-effectiveness
of ultra-hypo fractionated radiotherapy and conventionally fractionated radiotherapy for intermediate-to-high-risk
localized prostate cancer from the Chinese payer perspective.
Methods: We developed a Markov model with a 15-year time horizon to compare the cost and effectiveness of ultra-
hypo fractionated radiotherapy with those of conventionally fractionated radiotherapy for localized intermediate-
to-high-risk prostate cancer. Outcomes were measured in Quality-Adjusted Life-Years (QALYs), Incremental Cost-
Effectiveness Ratio (ICER), and Willingness-To-Pay (WTP). Univariable and probabilit.. View More»
DOI:
10.35248/IGOA.22.7.172